Oncol Lett 2011 Jan
Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy.   

Related Questions

If a patient develops a new erythematous macular rash in the exact area of the prior radiation portal months following completion of RT without new me...